PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer

por Liu, Lianqin, Li, Liu, Zu, Wufan, Jing, Jiayu, Liu, Guanjun, Sun, Tingyi, Xie, Qi
Publicado 2023

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer...

por Fan, Yangwei, Ma, Ke, Jing, Jiayu, Wang, Chuying, Hu, Yuan, Shi, Yu, Li, Enxiao, Geng, Qianqian
Publicado 2020

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review

por Wu, Yinying, Fan, Yangwei, Dong, Danfeng, Dong, Xuyuan, Hu, Yuan, Shi, Yu, Jing, Jiayu, Li, Enxiao
Publicado 2020

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways

por Hu, Yuan, Jing, Jiayu, Shi, Yu, Zhang, Pengchuang, Dong, Danfeng, Wu, Yinying, Dong, Xuyuan, Li, Enxiao, Fan, Yangwei
Publicado 2021

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades

por Shi, Yu, Fan, Yangwei, Hu, Yuan, Jing, Jiayu, Wang, Chuying, Wu, Yinying, Geng, Qianqian, Dong, Xuyuan, Li, Enxiao, Dong, Danfeng
Publicado 2019